SPONSOR
Alliance for Clinical Trials in Oncology
Total Trials
6
Recruiting
6
Phases
Phase 3, Phase 2
Conditions studied: Cigarette Smoking-Related CarcinomaHematopoietic and Lymphatic System NeoplasmLocalized Malignant Solid NeoplasmAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Early Stage Triple-Negative Breast CarcinomaIntracranial MeningiomaRecurrent MeningiomaNF2 Gene Mutation
Alliance for Clinical Trials in Oncology is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Cigarette Smoking-Related Carcinoma, Hematopoietic and Lymphatic System Neoplasm, Localized Malignant Solid Neoplasm, Anatomic Stage I Breast Cancer AJCC v8.
The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Alliance for Clinical Trials in Oncology
How many clinical trials has Alliance for Clinical Trials in Oncology sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Alliance for Clinical Trials in Oncology, of which 6 are actively recruiting participants. These trials cover conditions including Cigarette Smoking-Related Carcinoma, Hematopoietic and Lymphatic System Neoplasm, Localized Malignant Solid Neoplasm. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Alliance for Clinical Trials in Oncology research focus on?
Alliance for Clinical Trials in Oncology clinical trials span Cigarette Smoking-Related Carcinoma, Hematopoietic and Lymphatic System Neoplasm, Localized Malignant Solid Neoplasm, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, and additional conditions. The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Alliance for Clinical Trials in Oncology clinical trial?
To participate in a Alliance for Clinical Trials in Oncology trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Alliance for Clinical Trials in Oncology trials with current recruitment status updated daily.
Clinical Trials by Alliance for Clinical Trials in Oncology
NCT05008848 Phase 3
Recruiting
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
NCT07059884
Recruiting
Distance-Based Exercise to Preserve Function and Prevent Disability
Hematopoietic and Lymphatic System Neoplasm
NCT05812807 Phase 3
Recruiting
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage I Breast Cancer AJCC v8
NCT02523014 Phase 2
Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma
NCT03150693 Phase 3
Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
NCT07091617
Recruiting
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Miscellaneous Neoplasm, Nos
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology